2 weeks Ago By ABMN Staff
Fundamental Research set a $14.65 price objective on Zepp Health ( NYSE:ZEPP – Free Report ) in a research note published on Tuesday, BayStreet.CA reports.
The brokerage currently has a buy rating on the stock. Zepp Health Stock Performance Shares of ZEPP opened at $2.96 on Tuesday.
Zepp Health has a 1 year low of $2.06 and a 1 year high of $8.40.
The company has a debt-to-equity ratio of 0.13, a current ratio of 1.21 and a quick ratio of 0.
87. The stock’s fifty day moving average price is $3.36 and its two-hundred day moving average price is $3.
00. The firm has a market cap of $44.55 million, a PE ratio of -1.
18 and a beta of 0.68. Institutional Trading of Zepp Health An institutional investor recently bought a new position in Zepp Health stock.
Virtu Financial LLC acquired a new stake in shares of Zepp Health Co. ( NYSE:ZEPP – Free Report ) during the third quarter, according to its most recent filing with the SEC. The fund acquired 13,056 shares of the company’s stock, valued at approximately $57,000.
Virtu Financial LLC owned 0.09% of Zepp Health as of its most recent filing with the SEC. Hedge funds and other institutional investors own 52.
61% of the company’s stock. About Zepp Health Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products.
It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. See Also Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter .
.
